These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 25788263)
21. Down-regulation of Cbl-b by bufalin results in up-regulation of DR4/DR5 and sensitization of TRAIL-induced apoptosis in breast cancer cells. Yan S; Qu X; Xu C; Zhu Z; Zhang L; Xu L; Song N; Teng Y; Liu Y J Cancer Res Clin Oncol; 2012 Aug; 138(8):1279-89. PubMed ID: 22447040 [TBL] [Abstract][Full Text] [Related]
22. The reversal effects of 3-bromopyruvate on multidrug resistance in vitro and in vivo derived from human breast MCF-7/ADR cells. Wu L; Xu J; Yuan W; Wu B; Wang H; Liu G; Wang X; Du J; Cai S PLoS One; 2014; 9(11):e112132. PubMed ID: 25372840 [TBL] [Abstract][Full Text] [Related]
23. Small-molecule synthetic compound norcantharidin reverses multi-drug resistance by regulating Sonic hedgehog signaling in human breast cancer cells. Chen YJ; Kuo CD; Chen SH; Chen WJ; Huang WC; Chao KS; Liao HF PLoS One; 2012; 7(5):e37006. PubMed ID: 22615870 [TBL] [Abstract][Full Text] [Related]
24. Quercetin and doxorubicin co-encapsulated biotin receptor-targeting nanoparticles for minimizing drug resistance in breast cancer. Lv L; Liu C; Chen C; Yu X; Chen G; Shi Y; Qin F; Ou J; Qiu K; Li G Oncotarget; 2016 May; 7(22):32184-99. PubMed ID: 27058756 [TBL] [Abstract][Full Text] [Related]
25. Reversal of P-glycoprotein-mediated multidrug resistance by CD44 antibody-targeted nanocomplexes for short hairpin RNA-encoding plasmid DNA delivery. Gu J; Fang X; Hao J; Sha X Biomaterials; 2015 Mar; 45():99-114. PubMed ID: 25662500 [TBL] [Abstract][Full Text] [Related]
26. H19 non coding RNA-derived miR-675 enhances tumorigenesis and metastasis of breast cancer cells by downregulating c-Cbl and Cbl-b. Vennin C; Spruyt N; Dahmani F; Julien S; Bertucci F; Finetti P; Chassat T; Bourette RP; Le Bourhis X; Adriaenssens E Oncotarget; 2015 Oct; 6(30):29209-23. PubMed ID: 26353930 [TBL] [Abstract][Full Text] [Related]
27. Identification of GAS1 as an epirubicin resistance-related gene in human gastric cancer cells with a partially randomized small interfering RNA library. Zhao L; Pan Y; Gang Y; Wang H; Jin H; Tie J; Xia L; Zhang Y; He L; Yao L; Qiao T; Li T; Liu Z; Fan D J Biol Chem; 2009 Sep; 284(39):26273-85. PubMed ID: 19638344 [TBL] [Abstract][Full Text] [Related]
28. Knockdown of MDR1 increases the sensitivity to adriamycin in drug resistant gastric cancer cells. Zhu CY; Lv YP; Yan DF; Gao FL Asian Pac J Cancer Prev; 2013; 14(11):6757-60. PubMed ID: 24377601 [TBL] [Abstract][Full Text] [Related]
29. Rack1 Mediates the Interaction of P-Glycoprotein with Anxa2 and Regulates Migration and Invasion of Multidrug-Resistant Breast Cancer Cells. Yang Y; Wu N; Wang Z; Zhang F; Tian R; Ji W; Ren X; Niu R Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27754360 [TBL] [Abstract][Full Text] [Related]
30. Up-regulation of caveolae and caveolar constituents in multidrug-resistant cancer cells. Lavie Y; Fiucci G; Liscovitch M J Biol Chem; 1998 Dec; 273(49):32380-3. PubMed ID: 9829965 [TBL] [Abstract][Full Text] [Related]
31. DJ-1 is involved in the multidrug resistance of SGC7901 gastric cancer cells through PTEN/PI3K/Akt/Nrf2 pathway. Qiu L; Ma Z; Li X; Deng Y; Duan G; Zhao LE; Xu X; Xiao L; Liu H; Zhu Z; Chen H Acta Biochim Biophys Sin (Shanghai); 2020 Dec; 52(11):1202-1214. PubMed ID: 33079995 [TBL] [Abstract][Full Text] [Related]
32. An investigation of heat shock protein 27 and P-glycoprotein mediated multi-drug resistance in breast cancer using liquid chromatography-tandem mass spectrometry-based targeted proteomics. Xu F; Yang T; Fang D; Xu Q; Chen Y J Proteomics; 2014 Aug; 108():188-97. PubMed ID: 24882106 [TBL] [Abstract][Full Text] [Related]
33. Ubiquitin ligase Cbl-b represses IGF-I-induced epithelial mesenchymal transition via ZEB2 and microRNA-200c regulation in gastric cancer cells. Li H; Xu L; Li C; Zhao L; Ma Y; Zheng H; Li Z; Zhang Y; Wang R; Liu Y; Qu X Mol Cancer; 2014 Jun; 13():136. PubMed ID: 24885194 [TBL] [Abstract][Full Text] [Related]
34. γ-Tocotrienol reverses multidrug resistance of breast cancer cells through the regulation of the γ-Tocotrienol-NF-κB-P-gp axis. Ding Y; Fan J; Fan Z; Zhang K J Steroid Biochem Mol Biol; 2021 May; 209():105835. PubMed ID: 33556581 [TBL] [Abstract][Full Text] [Related]
35. Reversing P-Glycoprotein-Associated Multidrug Resistance of Breast Cancer by Targeted Acid-Cleavable Polysaccharide Nanoparticles with Lapatinib Sensitization. Sui J; He M; Yang Y; Ma M; Guo Z; Zhao M; Liang J; Sun Y; Fan Y; Zhang X ACS Appl Mater Interfaces; 2020 Nov; 12(46):51198-51211. PubMed ID: 33147005 [TBL] [Abstract][Full Text] [Related]
36. Reversing of multidrug resistance breast cancer by co-delivery of P-gp siRNA and doxorubicin via folic acid-modified core-shell nanomicelles. Wu Y; Zhang Y; Zhang W; Sun C; Wu J; Tang J Colloids Surf B Biointerfaces; 2016 Feb; 138():60-9. PubMed ID: 26655793 [TBL] [Abstract][Full Text] [Related]
37. Psoralen reverses the P-glycoprotein-mediated multidrug resistance in human breast cancer MCF-7/ADR cells. Jiang J; Wang X; Cheng K; Zhao W; Hua Y; Xu C; Yang Z Mol Med Rep; 2016 Jun; 13(6):4745-50. PubMed ID: 27082231 [TBL] [Abstract][Full Text] [Related]
38. Paris saponin VII reverses chemoresistance in breast MCF-7/ADR cells. Li Y; Sun Y; Tang T; Niu Y; Li X; Xie M; Jin H; Mei Q J Ethnopharmacol; 2019 Mar; 232():47-54. PubMed ID: 30552993 [TBL] [Abstract][Full Text] [Related]
39. Adenovirus-mediated p53 gene therapy reverses resistance of breast cancer cells to adriamycin. Qi X; Chang Z; Song J; Gao G; Shen Z Anticancer Drugs; 2011 Jul; 22(6):556-62. PubMed ID: 21637162 [TBL] [Abstract][Full Text] [Related]
40. Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318. Chen LM; Liang YJ; Ruan JW; Ding Y; Wang XW; Shi Z; Gu LQ; Yang XP; Fu LW J Pharm Pharmacol; 2004 Aug; 56(8):1061-6. PubMed ID: 15285852 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]